SHUNT OCCLUSION side effect
What is SHUNT OCCLUSION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
SHUNT OCCLUSION and Recently Reported Side Effects
SHUNT OCCLUSION and 15 most Active Side Effect polls
SHUNT OCCLUSION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Rituximab Side Effects Report #5665168-8
Physician from UNITED KINGDOM reported RITUXIMAB problem on Mar 03, 2008. Male patient, weighting 183.0 lb, was diagnosed with renal transplant and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . RITUXIMAB dosage: 750 MG, SINGLE. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, METOPROLOL TARTRATE, CALCIUM CARBONATE, SEVELAMER HYDROCHLORIDE, ALFACALCIDOL. Patient recovered.
Aranesp Side Effects Report #5519435-9
ARANESP problem was reported by a Physician from GERMANY on Nov 08, 2007. Female patient, 64 years of age, weighting 170.9 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, VITAMIN B, ASCORBIC ACID, INSULIN, CALCIUM, FERRLECIT. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5519441-4
Physician from GERMANY reported ARANESP problem on Nov 08, 2007. Female patient, 71 years of age, weighting 135.6 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, VITAMIN B, ASCORBIC ACID, INSULIN, CALCITRIOL, CALCIUM ACETATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5465388-1
ARANESP problem was reported by a Physician from GERMANY on Sept 14, 2007. Female patient, 67 years of age, weighting 141.1 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with VITAMIN D, VITAMIN B, ASCORBIC ACID, ANTIHYPERTENSIVES, FERRLECIT, CALCIUM. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5405044-9
Physician from GERMANY reported ARANESP problem on July 27, 2007. Female patient, 67 years of age, weighting 141.1 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with VITAMIN D, VITAMIN B, ASCORBIC ACID, ANTIHYPERTENSIVES, FERRLECIT, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5405053-X
ARANESP problem was reported by a Physician from GERMANY on July 26, 2007. Female patient, 71 years of age, weighting 135.6 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, VITAMIN B, ASCORBIC ACID. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5405057-7
Physician from GERMANY reported ARANESP problem on July 26, 2007. Female patient, 64 years of age, weighting 170.9 lb, was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, VITAMIN B, ASCORBIC ACID, INSULIN, CALCIUM CHLORIDE, FERRLECIT. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5393727-9
ARANESP problem was reported by a Physician from GERMANY on July 11, 2007. Female patient, 67 years of age, weighting 141.1 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with VITAMIN D, VITAMIN B, ASCORBIC ACID, ANTIHYPERTENSIVES, FERRLECIT, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Novoseven Side Effects Report #5400057-5
Physician from GERMANY reported NOVOSEVEN problem on July 18, 2007. Female patient was diagnosed with prophylaxis and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . NOVOSEVEN dosage: unknown. During the same period patient was treated with PLATELET AGGREGATION INHIBITORS, ASPIRIN, PLAVIX. Patient was hospitalized. Patient recovered.
Aranesp Side Effects Report #5393727-9
ARANESP problem was reported by a Physician from GERMANY on July 11, 2007. Female patient, 67 years of age, weighting 141.1 lb, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . ARANESP dosage: unknown. During the same period patient was treated with VITAMIN D, VITAMIN B, ASCORBIC ACID, ANTIHYPERTENSIVES, FERRLECIT, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Novoseven Side Effects Report #5400057-5
Physician from GERMANY reported NOVOSEVEN problem on July 18, 2007. Female patient was diagnosed with prophylaxis and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . NOVOSEVEN dosage: unknown. During the same period patient was treated with PLATELET AGGREGATION INHIBITORS, ASPIRIN, PLAVIX. Patient was hospitalized. Patient recovered.
Novoseven Side Effects Report #5322069-2
NOVOSEVEN problem was reported by a Physician from GERMANY on Apr 30, 2007. Female patient was diagnosed with prophylaxis and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: shunt occlusion, . NOVOSEVEN dosage: unknown. During the same period patient was treated with PLATELET AGGREGATION INHIBITORS. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5663927-9
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Feb 27, 2008. Female patient, 28 years of age, weighting 210.0 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: muscle spasms, shunt occlusion, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5664060-2
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2008. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: protein total increased, shunt occlusion, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Aldurazyme Side Effects Report #5390955-3
Physician from UNITED STATES reported ALDURAZYME problem on July 28, 2006. Female patient, 23 years of age, weighting 127.2 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: headache, shunt occlusion, . ALDURAZYME dosage: 0.58 MG/KG QWK IV. During the same period patient was treated with TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.
Aldurazyme Side Effects Report #5390955-3
ALDURAZYME problem was reported by a Physician from UNITED STATES on July 28, 2006. Female patient, 23 years of age, weighting 127.2 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: headache, shunt occlusion, . ALDURAZYME dosage: 0.58 MG/KG QWK IV. During the same period patient was treated with TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5723834-X
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Apr 17, 2008. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: protein total increased, shunt occlusion, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Omniscan Side Effects Report #5366982-9
OMNISCAN problem was reported by a Health Professional from JAPAN on June 08, 2007. Female patient was diagnosed with shunt occlusion and was treated with OMNISCAN. After drug was administered, patient experienced the following problems/side effects: nephrogenic fibrosing dermopathy, shunt occlusion, . OMNISCAN dosage: 20 ML, SINGLE DOSE, I.V.. Patient recovered.